Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors
Title:
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors
Author:
Chun, Yong Soon Yoshida, Takahiro Mori, Tsuyoshi Huso, David L. Zhang, Zhe Stearns, Vered Perkins, Brandy Jones, Richard J. Sukumar, Saraswati